Skip to Content

Dimethyl sulfoxide Pregnancy and Breastfeeding Warnings

Dimethyl sulfoxide is also known as: Cryoserv, Rimso-50

Medically reviewed on September 11, 2018

Dimethyl sulfoxide Pregnancy Warnings

FDA pregnancy category: C

Potential benefit should outweigh the potential risk.

Dimethyl sulfoxide caused teratogenic responses in animals when administered intraperitoneally at high doses. Oral doses did not cause problems of reproduction in animals. In one study topical doses produced terata in animals, but in another study topical dose failed to produce any abnormalities.

There are no controlled data in human pregnancy.

FDA pregnancy category C: Animal reproduction studies have shown an adverse effect on the fetus and there are no adequate and well-controlled studies in humans, but potential benefits may warrant use of the drug in pregnant women despite potential risks.

See references

Dimethyl sulfoxide Breastfeeding Warnings

Caution is recommended.

Excreted into human milk: Unknown
Excreted into animal milk: Unknown

The effects in the nursing infant are unknown.

See references

References for pregnancy information

  1. "Product Information. Rimso-50 (dimethyl sulfoxide)." Edwards Lifesciences, Irvine, CA.

References for breastfeeding information

  1. "Product Information. Rimso-50 (dimethyl sulfoxide)." Edwards Lifesciences, Irvine, CA.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide